This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Drug Topics spoke to father and son pharmacist duo Grant and Austin Brown for a conversation about the evolution of the practice, the importance of holding elected officials accountable, and more.
The 340B Drug Pricing Program has grown yet again , exceeding $100 billion in sales in 2022 when 340B-priced medicines are measured at wholesale acquisition cost. Recent data from IQVIA shows 340B grew 12.2% year-over-year in 2022, continuing a trend in which 340B sales have almost doubled since 2018, outpacing growth of the total U.S. drug market.
Greg Mitchell joined Drug Topics to talk about the importance of community when you are a rural pharmacy, what challenges he's faced, and the power of joining a cooperative.
Pharmacogenomics is gaining support in mental health and polypharmacy, where the data make a strong case for improvements in clinical and economic outcomes.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
When it comes to pursuing a career in pharmacy, some may assume that it’s exclusively suited for those who have a strong scientific and mathematical background and analytical personality. However, this couldn’t be further from the truth. In fact, creative individuals can also find fulfilling careers in pharmacy, and here are a few reasons why.
The FDA’s Antimicrobial Drugs Advisory Committee decided to recommend nirsevimab (Beyfortus) for the prevention of respiratory syncytial virus (RSV) disease in infants.
The FDA’s Antimicrobial Drugs Advisory Committee decided to recommend nirsevimab (Beyfortus) for the prevention of respiratory syncytial virus (RSV) disease in infants.
The big pharma patent cliff is almost here — and could change the face of the industry. Here’s a look at the key stats behind the coming wave of blockbuster losses.
Over 90% of respondents to a recent U.S. News and World Report survey said their goal is to age in place. | More than 90% of respondents to a recent U.S. News and World Report survey said their goal is to age in place. A whopping 88% also reported that assistive or health-related technologies have improved their quality of life.
Digital health companies should brace for a shake-up as COVID-era contracts inked with hospitals will soon be up for renewal, according to the results of a recent survey. | Numerous digital health contracts signed by hospitals reacting to COVID-19 are nearing their conclusion, giving many providers a chance to reevaluate their options, a recent executive survey suggests.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
In-person visits to receive oral therapy, outpatient infusions, and inpatient infusion for the treatment of hematologic neoplasms declined in the early months of the COVID-19 pandemic, while telemedicine use increased slightly in the same period but remained low overall.
Endometriosis, a common gynecological condition, is one of health’s great mimickers. It can manifest as a variety of painful symptoms but evade detection on scans and examinations. And for the estimated 10% to 15% of women with endometriosis, it can take over a decade to get a diagnosis. Part of the lag is because researchers still don’t know exactly how endometriosis occurs, except that the flow of menstrual blood backward through the fallopian tubes plays a role in some cases.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
While national health spending growth slowed in 2022, that trend isn't likely to stick around. | While national health spending growth slowed in 2022, that trend isn't likely to stick around, actuaries at CMS said Wednesday.
Insurance giant UnitedHealth Group's stock was down Wednesday after executives warned that higher medical costs are likely for the second quarter. | Insurance giant UnitedHealth Group's stock was down on Wednesday after executives warned that higher medical costs are likely for the second quarter.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Sanofi is jumping on the artificial intelligence boat with a new app and a pledge to become “the first pharma company powered by artificial intelligence at scale.” | Sanofi's new app, plai, provides teams with a “360° view" to aid decision-making. The platform is one step in the company's digital transformation and goal to become the "first pharma powered by AI at scale.
Cerner brought in $1.5 billion in revenue in the latest quarter, boosting strong growth for enterprise software giant Oracle. | Cerner brought in $1.5 billion in revenue in the latest quarter, boosting strong growth for enterprise software giant Oracle. But hospital CIOs who use Cerner continue to have reservations about the future of the EHR company, citing the lack of a concrete road map.
For three years, nine months, and one week, Ram Sasisekharan lived under a gag order. In 2019, some of the Massachusetts Institute of Technology professor’s peers publicly accused his lab of falsifying research, setting in motion a lengthy internal investigation that sidelined his work, decimated his team, and barred him from speaking out in his own defense.
Two Chairs, a hybrid behavioral health provider, launched a customized clinician dashboard for delivering measurement-based care. | The therapist-facing platform analyzes patient data with the goal of enabling therapists to quickly adjust treatment plans and improve outcomes.
The country’s largest physician organization is taking a strong stance against noncompete contracts for physicians and is redoubling efforts to urge Congress to boost Medicare payments. | The country’s largest physician organization is taking a strong stance against noncompete contracts for physicians and is redoubling efforts to urge Congress to boost Medicare payments.
An FTC lawsuit aimed at blocking Amgen’s $27.8 billion buyout o | An FTC lawsuit aimed at blocking Amgen’s $27.8 billion buyout of Horizon Therapeutics has raised concerns that the United States’ antitrust watchdog is tightening the screws on major M&A moves in the biopharma industry. A month later, according to an SEC filing, Pfizer has withdrawn its notification for its proposed $43 billion acquisition of cancer drug specialist Seagen and will submit another later in the day.
Harvard Pilgrim Health Care and its parent company, Point32Health, have been hit with a class-action lawsuit for allegedly failing to secure the personal information of over 2.5 million people. | Harvard Pilgrim Health Care and its parent company, Point32Health, have been hit with a class action lawsuit for allegedly failing to secure the personal information of over 2.5 million people.
A top executive at UnitedHealth Group said Tuesday that the health insurance and services conglomerate has noticed “a meaningfully higher number” of outpatient visits among Medicare patients in the second quarter of this year. The trend indicates a lot of older adults are getting care they had previously put off, which would eat into insurers’ earnings.
Pharma1 Pharmacy & Wellness Center in McKinney, TX is not your average pharmacy. As soon as you step through the door, you get a relaxed, spa-like feel from.
Rise and shine, everyone. The middle of the week is upon us. Have heart, though. You made it this far, so why not hang on for another couple of days, yes? And what better way to make the time fly than to keep busy. So grab that cup of stimulation — our flavor today boasts the aroma of pumpkins — and get started. To help you along, we have assembled another menu of tidbits for you to peruse.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content